Zimmer Biomet (ZBH) Competitors

Zimmer Biomet (NYSE:ZBH) and Penumbra (NYSE:PEN) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

Do institutionals & insiders believe in ZBH or PEN?

88.9% of Zimmer Biomet shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 0.7% of Zimmer Biomet shares are held by insiders. Comparatively, 5.0% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has stronger earnings and valuation, ZBH or PEN?

Zimmer Biomet has higher revenue and earnings than Penumbra. Zimmer Biomet is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$7.68B	2.71	$903.70M	$4.11	25.55
Penumbra	$1.28B	8.21	$14.01M	$3.76	71.71

Do analysts recommend ZBH or PEN?

Zimmer Biomet presently has a consensus price target of $111.44, indicating a potential upside of 6.11%. Penumbra has a consensus price target of $300.44, indicating a potential upside of 11.43%. Given Penumbra's stronger consensus rating and higher possible upside, analysts clearly believe Penumbra is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	2 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.35
Penumbra	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.95

Does the media prefer ZBH or PEN?

In the previous week, Zimmer Biomet had 9 more articles in the media than Penumbra. MarketBeat recorded 25 mentions for Zimmer Biomet and 16 mentions for Penumbra. Zimmer Biomet's average media sentiment score of 1.23 beat Penumbra's score of 1.18 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	12 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	11 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, ZBH or PEN?

Zimmer Biomet has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500.

Is ZBH or PEN more profitable?

Penumbra has a net margin of 11.54% compared to Zimmer Biomet's net margin of 10.51%. Zimmer Biomet's return on equity of 12.76% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	10.51%	12.76%	7.21%
Penumbra	11.54%	11.55%	8.76%

Summary

Penumbra beats Zimmer Biomet on 9 of the 17 factors compared between the two stocks.